ABSTRACT
INTRODUCTION
Breast cancer is the second most common type of cancer after lung cancer and the fifth most common cause of cancer death among both sexes worldwide
(1) . The etiology of breast cancer is multifactorial. Significant breast cancer risk factors include age, early age at menarche, late age of menopause, late age at first pregnancy, obesity, oral contraception, HRT (hormone replacement therapy), diet, family history, lactation and prior history of benign breast disease (2) . Although benign breast conditions are not life-threatening as breast cancer, benign lesions of the breast are far more frequent than cancerous ones and can cause serious physical symptoms, a financial burden for health services and emotional problems for patients and families since certain benign conditions are linked with an increased risk of developing breast cancer (3) . The development of breast cancer has been linked to the degree of oxidative stress, particularly with perturbations in the delicate balance between reactive oxygen species (ROS) and oxidative defenses . Oxidative stress has been demonstrated to induce cell death as a result of excessive cellular damage associated with lipid peroxidation and alterations of nucleic acids and proteins, triggering apoptosis through the mitochondria
(7)
. Nitric oxide (NO), which is synthesized by nitric oxide synthase, is a multi-function signaling molecule controlling vasodilatation, platelet aggregation, immunocytotoxicity and carcinogenesis (8,9) . Analysis of nitrite and nitrate has been used extensively as an index of endogenous production of NO in biological systems, with respect to various pathological processes. Reactive . The aim of the present study was to asses the association between MnSOD gene polymorphism and risk of both breast cancer and benign breast disorders, and to determine the alteration in oxidant-antioxidant status.
PATIENTS AND METHODS

Patients:
Twenty four females patients with newly detected breast cancer were diagnosed clinically, radiologicaly and confirmed by histopathological examination. They were classified using TNM system (Table1). Their ages ranged 35-51 years. Twenty seven female patients with benign breast fibroadenoma were involved; their ages ranged 35-47 years. All patients were recruited from Surgery Department, Sohag University Hospital during the period from January 2012 to September 2013. The control group included twenty three healthy females without any history of breast cancer or previous benign breast problems, their age ranged 36-47 years (Table 2) .
A structured questionnaire was obtained to elicit detailed information on demographic factors, menstrual and reproductive histories, hormone use, dietary habit, family history of cancer, also, current weight and height were measured, then calculating the body mass index (BMI). The University of Sohag Ethics Committee approved the study and informed consent was obtained from all participants according to the study protocol.
Methods:
Fresh tumor and benign tissues samples obtained from patients immediately after surgery. Normal breast tissue from reduction mammoplasty specimens provided as a control .The study materials were washed with saline three times, kept in vials, and stored at -20˚C until analysis. The tissues were weighed and homogenized under standardized conditions.
From each patients and control subjects 5ml venous blood samples were collected and pipetted into two tubes, one with heparin anticoagulant for the whole blood, and the other without anticoagulant, then centrifuged, the serum was separated in aliquot and stored at -20 ˚C until assay.
Tissue homogenization:
All breast tissues (cancer, benign and control) were homogenized in 10 volumes of 50 mM sodium phosphate buffer (pH 7.4) for 30 sec. using a glass-Col (TURBAX-Germany) Genomic DNA was extracted from whole heparinized blood samples, using CinnaPure DNA kits (Cat No. PR881612) provided CinnaPure Tehran). MnSOD genotyping was conducted using polymerase chain reaction-restriction fragment length polymorphism (CR-RFLP) as described by Cai et al (26) . PCR amplification was carried out using forward primer (5'-CCAGCAGGCAGCTGGCGCCGG-3') reversed primer (5'-CGTTGATGTGAGGTTCCAG-3'). Table ( 3) showed significant elevations of serum NO mean levels in breast cancer patients compared to both control subjects and patients with benign breast lesions the latter mean level is not significantly different from that of controls. NO levels in breast cancer tissues were significantly higher compared to both control subjects and patients with benign breast lesions also the latter mean level is significantly higher compared to that of controls. Serum MDA levels in breast cancer patients were not significantly different compared to both control subjects and patients with benign breast lesions. MDA mean levels in breast cancer tissues were significantly higher compared to both control subjects and patients with benign breast lesions, the latter mean level is not significantly different from that of controls. Serum total SOD mean activity of breast cancer patients was significantly lower compared to both control subjects and patients with benign breast lesions, the latter mean level is not significantly different from that of controls. Total SOD mean activity in breast cancer tissues were significantly lower compared to both control subjects and patients with benign breast lesions, the latter mean activity is not significantly different from that of controls. Table ( 4) demonstrated that in breast cancer patients Ala/Val is the most prominent (66.7%), in benign breast lesions, the most prominent was Val/Val (40.8%), and in the control subjects, the most prominent was also, Val/Val (69.6%). In investigation of Ala/Val polymorphism odd ratio was significant higher in breast cancer patients (p= 0.03) as shown in table (5).
RESULTS
DISCUSSION
Breast cancer is one of the most common neoplasm in women and is a leading cause of cancer related deaths (27) . 
SOD
is of marked pathophysiological importance. It was studied primarily as a defense mechanism against the consequences of free radical production
(40)
. A recent study demonstrates a novel therapeutic strategy to inhibit cell death and apoptosis caused by ROS, via increasing antioxidant potential, which can be overcome by treatment with SOD modulators (41) . The inconsistency in the result is likely due to the heterogeneity of the tumor tissue (42) , and the method which was used to measure this enzyme activity. However, the obtained data remain unclear because SOD activity varies greatly, according to the different conditions in each study. Since the causes and biochemical profile of breast cancer are not yet fully known and there is no clear mechanism by which oxygen radicals may affect the outcome of breast cancer. Our result showed that there is significant decrease of SOD in breast cancer in comparison to control, a result which agrees with those of Abiaka et al. (43) who reported decreased SOD in erythrocytes of patients with breast cancer. However Portakal et al. (44) found that total SOD activity in breast tumor tissues was significantly higher than that in corresponding cancer-free tissues. Furthermore, oxidative DNA damage is reportedly increased in breast cancer tissue relative to normal breast (45) . MnSOD, one of the major antioxidant enzymes, catalyzes the dismutation of superoxide radicals to H 2 O 2 and oxygen in mitochondria and thus constitutes first-line defense against ROS in mitochondria. Hence, it is conceivable that structural and/or functional polymorphisms of MnSOD gene are of immense importance in the maintenance of ROS levels in cell. Low expression of MnSOD has often been accounted for different types of cancer formation; the association observed from our results could be explained by some biochemical evidences that suggests association between breast cancer and oxidative stress metabolism (46) .
The most commonly studied polymorphism of MnSOD is Val
16 Ala on mitochondrial target sequence. It is a single nucleotide polymorphism (SNP) in codon 16. A substitution of T to C at nucleotide 47 changes the encoded amino acid from Val (GTT) to Ala (GCT) on the 16th residue of 24-amino acid signal sequence that helps in targeting the nascent protein to mitochondria. This residue is 9-amino acid upstream of the cleavage site, hence, has often been designated as Ala 9 Val polymorphism
(21)
. A newly synthesized MnSOD is transported to mitochondria where it is assembled into a homotetramer. ShimodaMatsubayashi et al. (20) predicted that Val allele would encode a β-sheet conformation rather than a preferred α-helical structure of MnSOD precursor protein that leads to an impaired transport of MnSOD to mitochondria. Sutton et al. (47) found that the Ala form of MnSOD is targeted into the mitochondria, whereas the Val form is partially arrested in the inner mitochondrial membrane. Their study revealed that Ala form of MnSOD was 30% to 40% more efficiently localized to the mitochondria than the Val form. In view of these findings, it is expected that the Val form is likely to be associated with higher levels of ROS and thus predisposes to a greater risk of cancer.
Our result shows that MnSOD genotyping revealed that Ala/Val genotype had the highest distribution for cancer group (66.7%) and were in agreement with the findings of Ambrosone et al.
(5) , Mitrunen e t al (48) and Cai et al (26) , which all based on the fact that the Ala-containing MnSOD is transported more efficiently through the mitochondrial membrane , were explained by the possible highly active Ala-containing MnSOD that could cause accumulation of H 2 O 2 in mitochondria at least in the absence of H 2 O 2 -scavenging enzymes such as glutathione peroxidase and catalase, which could lead to oxidative damage and consequently cancer. It could be concluded that variation in key antioxidant enzymes with high level of oxidative stress are long speculated risk factors for the genetic susceptibility for cancer development. Genetic polymorphism in MnSOD gene may be associated with increased risk of breast cancer, however, studies with more patients and oxidative stress-related parameters are required, also, exogenous administration of antioxidant, may be helpful in the management of breast cancer.
In summary, the current study investigated the relationship between high serum NO and tissue NO and MDA with low serum and tissue SOD and ALA/VAL MnSOD polymorphism in breast cancer. It is recommended to investigate the correlation of these varieties with each specific breast cancer cell types 
